A new genomic framework to categorize pediatric acute myeloid leukemia

M Umeda, J Ma, T Westover, Y Ni, G Song… - Nature Genetics, 2024 - nature.com
Recent studies on pediatric acute myeloid leukemia (pAML) have revealed pediatric-specific
driver alterations, many of which are underrepresented in the current classification schemas …

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

RE van Weelderen, CJ Harrison, K Klein… - Blood …, 2024 - ashpublications.org
A comprehensive international consensus on the cytogenetic risk-group stratification of
KMT2A-rearranged (KMT2A-r) pediatric acute myeloid leukemia (AML) is lacking. This …

Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP/EBMT study

A Sharma, JE Galimard, A Pryce… - Bone Marrow …, 2024 - nature.com
Abstract Poor-risk (PR) cytogenetic/molecular abnormalities generally direct pediatric
patients with acute myeloid leukemia (AML) to allogeneic hematopoietic stem cell transplant …

[HTML][HTML] Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran

M Heidary Sadegh, M Mozafari, M Vasei… - Middle East Journal …, 2024 - journals.sums.ac.ir
Background: Acute myeloid leukemia (AML) accounts for 15%-20% of childhood leukemia.
A variety of cytogenetic abnormalities have been reported in AML, but it is still debated how …

[PDF][PDF] Classic and molecular cytogenetic findings in leukemia patients from the Western part of Romania

CA POPA, NI ANDREESCU, TS ARGHIRESCU… - rjme.ro
Acute lymphoblastic leukemia (ALL) is the most common type of leukemia in childhood and
rare in adults, while acute myeloid leukemia (AML) is less common in children and more …

急性骨髄性白血病における同種造血細胞移植の適応: 小児科医の視点

富澤大輔 - 日本造血・免疫細胞療法学会雑誌, 2024 - jstage.jst.go.jp
抄録 小児急性骨髄性白血病 (AML) における同種造血細胞移植の適応は, 白血病細胞固有の細胞
遺伝学的異常/分子遺伝学的異常および治療反応性に基づいて決定されるが …